Abviris Deutschland

Abviris Deutschland is a German private diagnostics company focused on blood-based and rapid in vitro diagnostic tests for HPV16-associated cancers. The company develops, manufactures, and markets immunology-based diagnostic products and medical devices aimed at early detection and monitoring of HPV-induced tumors. Its lead commercial product, Prevo-Check, is positioned as a rapid blood-based screening test for HPV16-induced cancers, particularly oral and oropharyngeal disease, and the company also markets the DRH1 tumor marker for patient monitoring. Founded in 2014, Abviris has operated in northern Germany and has emphasized HPV serology, proprietary antibodies, and point-of-care oncology diagnostics. Corporate registry sources indicate the company remains registered and active, though it has undergone insolvency-related proceedings and subsequent restructuring.